GO:0002502 peptide antigen assembly with MHC class I protein complex: Assembly Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0002502 describes the binding of a peptide to the antigen-binding groove of a classical MHC class I protein complex, a critical step in adaptive immunity.
• The process occurs mainly in the endoplasmic reticulum (ER) and involves a peptide-loading complex (PLC) comprising TAP1, TAP2, tapasin, ERp57, and calreticulin.
• Peptide editing by tapasin ensures that high-affinity peptides are preferentially loaded onto MHC class I molecules.
• Defects in peptide assembly lead to impaired CD8+ T cell responses and are associated with cancer immune evasion, viral infections, and autoimmune diseases.
• MHC class I assembly can also occur in endolysosomal compartments, diversifying the immunopeptidome.
• CRISPR-based knockout, knock-in, and point-mutation models are powerful tools to dissect the molecular players in this pathway.
Description
The term GO:0002502, peptide antigen assembly with MHC class I protein complex, refers to the binding of a peptide to the antigen-binding groove of a classical MHC class I molecule. This step is the culmination of the MHC class I antigen processing pathway and is essential for presenting intracellular antigens to CD8+ cytotoxic T lymphocytes. The assembly process ensures that only high-affinity peptides are displayed on the cell surface, enabling immune surveillance of infected or transformed cells. Researchers study this process to understand immune recognition, vaccine design, and cancer immunotherapy. The molecular machinery involved includes the transporter associated with antigen processing (TAP), tapasin, ERp57, and calreticulin, which together form the peptide-loading complex (PLC). Recent evidence indicates that MHC class I assembly can also occur in endolysosomal compartments, expanding the repertoire of presented peptides. This article provides a comprehensive overview of the definition, mechanism, key genes, regulation, disease relevance, and research methods for GO:0002502.
peptide antigen assembly with MHC class I protein complex At A Glance
| GO ID | GO:0002502 |
|---|---|
| GO term | peptide antigen assembly with MHC class I protein complex |
| Ontology | biological_process |
| Synonym | None |
| Major function | Loading of peptide antigens onto MHC class I molecules for presentation to CD8+ T cells |
| Cellular location | Endoplasmic reticulum and endolysosomal compartments |
| Key components | MHC class I heavy chain, beta-2-microglobulin, TAP1, TAP2, tapasin, ERp57, calreticulin |
| Related process | Antigen processing and presentation (GO:0019882) |
What Is GO:0002502?
GO:0002502 is defined as the binding of a peptide to the antigen-binding groove of an MHC class I protein complex, where class I refers to classical class I molecules. This process is a key step in antigen presentation, allowing the immune system to detect abnormal cells.
Why Is peptide antigen assembly with MHC class I protein complex Important in Cell Biology?
Peptide antigen assembly with MHC class I protein complex is fundamental for adaptive immunity, as it determines which peptides are presented to CD8+ T cells and thus shapes immune responses against pathogens and tumors. Dysregulation of this process can lead to immune evasion by cancer cells, chronic viral infections, and autoimmunity. Understanding the molecular details of this assembly is crucial for developing immunotherapies, vaccines, and diagnostics.
• Enables CD8+ T cell-mediated killing of infected or malignant cells.
• Determines the immunopeptidome and thus the specificity of immune responses.
• Defects in assembly cause bare lymphocyte syndrome and immune deficiency.
• Tumor cells often downregulate MHC class I assembly to escape immune detection.
• Viral proteins can interfere with peptide loading to evade immunity.
• Tapasin-mediated peptide editing ensures high-affinity peptide selection.
• Endolysosomal MHC class I assembly diversifies antigen presentation.
• Targeting this pathway can enhance cancer immunotherapy efficacy.
• Assembly components are potential biomarkers for immune-related diseases.
• CRISPR screens can identify novel regulators of this process.
What Happens During peptide antigen assembly with MHC class I protein complex?
Peptide Generation and Transport into the ER
In simple terms: Proteins in the cytosol are cut into small pieces and pumped into the endoplasmic reticulum.
Cytosolic proteins are degraded by the proteasome into peptides, which are then transported into the endoplasmic reticulum (ER) by the TAP1/TAP2 heterodimer. This step is essential for providing the peptide cargo for MHC class I assembly.
Formation of the Peptide-Loading Complex (PLC)
In simple terms: A group of chaperone proteins assembles to help load peptides onto MHC class I.
In the ER, the MHC class I heavy chain binds to beta-2-microglobulin and associates with the PLC, which includes TAP1, TAP2, tapasin, ERp57, and calreticulin. Tapasin bridges the MHC class I molecule to TAP and facilitates peptide loading.
Peptide Binding and Editing
In simple terms: The MHC molecule tests different peptides and selects the best-fitting one.
Tapasin acts as a peptide editor, favoring the binding of high-affinity peptides to the MHC class I groove. This editing function ensures that only stable peptide-MHC complexes are released from the ER.
Release and Surface Presentation
In simple terms: The loaded MHC molecule travels to the cell surface to show the peptide to immune cells.
Once a high-affinity peptide is bound, the MHC class I complex dissociates from the PLC and is transported through the Golgi to the cell surface. There, it presents the peptide to CD8+ T cells.
Endolysosomal MHC Class I Assembly
In simple terms: Some MHC class I molecules also pick up peptides in other compartments.
Recent studies show that MHC class I molecules can also assemble with peptides in endolysosomal compartments, contributing to a broader immunopeptidome. This pathway may be important for cross-presentation and immune surveillance.
Key Genes Involved in GO:0002502 peptide antigen assembly with MHC class I protein complex
The following genes and proteins are central to peptide antigen assembly with MHC class I protein complex.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HLA-A | MHC class I heavy chain; binds peptide | Target for knockout to study antigen presentation |
| HLA-B | MHC class I heavy chain; binds peptide | Polymorphisms affect peptide repertoire |
| HLA-C | MHC class I heavy chain; binds peptide | Regulates NK cell education |
| B2M | Beta-2-microglobulin; stabilizes MHC I | Knockout abolishes surface MHC I |
| TAP1 | Peptide transporter subunit | Mutations cause immune deficiency |
| TAP2 | Peptide transporter subunit | Required for peptide supply |
| TAPBP | Tapasin; peptide editor and bridge | Knockout impairs peptide loading |
| PDIA3 | ERp57; disulfide isomerase in PLC | Facilitates MHC I folding |
| CALR | Calreticulin; chaperone in PLC | Assists in MHC I assembly |
| CANX | Calnexin; chaperone for MHC I | Early folding of heavy chain |
| PSMB8 | Immunoproteasome subunit | Generates peptides for MHC I |
| PSMB9 | Immunoproteasome subunit | Generates peptides for MHC I |
| PSMB10 | Immunoproteasome subunit | Generates peptides for MHC I |
| ERAP1 | Aminopeptidase; trims peptides | Shapes peptide repertoire |
| ERAP2 | Aminopeptidase; trims peptides | Shapes peptide repertoire |
| RNF185 | E3 ubiquitin ligase; regulates tapasin | Controls MHC I surface expression |
| MBRL | Membralin; part of RNF185 complex | Regulates tapasin stability |
How Is peptide antigen assembly with MHC class I protein complex Regulated?
The assembly of peptide with MHC class I is regulated at multiple levels. Tapasin expression and stability are controlled by the RNF185/Membralin ubiquitin ligase complex, which mediates ER-associated degradation of unassembled tapasin, thereby influencing MHC class I surface levels. Additionally, the peptide repertoire is shaped by the activity of ERAP1 and ERAP2 aminopeptidases, which trim peptides to optimal length for MHC class I binding. The immunoproteasome subunits PSMB8, PSMB9, and PSMB10 are induced by interferon-gamma and alter peptide generation. Furthermore, the PLC assembly is subject to quality control mechanisms that ensure only properly folded MHC class I molecules progress to the cell surface.
peptide antigen assembly with MHC class I protein complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| B2M | Cancer immune evasion, melanoma | B2M knockout melanoma cell lines |
| TAP1 | Bare lymphocyte syndrome type I | TAP1 knockout iPSCs |
| TAPBP | Bare lymphocyte syndrome type I | Tapasin knockout HeLa cells |
| ERAP1 | Autoimmunity, ankylosing spondylitis | ERAP1 point-mutation knock-in mice |
| HLA-A | Autoimmunity, cancer | HLA-A transgenic models |
Cancer Immune Evasion
Tumor cells frequently downregulate components of the MHC class I peptide assembly pathway, such as B2M, TAP1, or tapasin, to escape CD8+ T cell recognition. This downregulation is associated with resistance to immunotherapy and poor clinical outcomes.
Viral Infections
Viruses encode proteins that interfere with peptide loading onto MHC class I. For example, herpes simplex virus ICP47 blocks TAP-mediated peptide transport, while human cytomegalovirus US6 inhibits TAP function, leading to reduced MHC class I surface expression and immune evasion.
Autoimmune Diseases
Alterations in peptide editing or MHC class I assembly can lead to presentation of self-peptides, contributing to autoimmune conditions such as type 1 diabetes and rheumatoid arthritis. Polymorphisms in ERAP1 and HLA class I genes are associated with autoimmune risk.
Primary Immunodeficiencies
Mutations in TAP1, TAP2, or tapasin cause bare lymphocyte syndrome type I, characterized by severe reduction in MHC class I surface expression and recurrent respiratory infections.
From peptide antigen assembly with MHC class I protein complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of tapasin affect MHC I surface expression? | TAPBP knockout cell line |
| How does a specific ERAP1 polymorphism alter peptide trimming? | ERAP1 point-mutation knock-in |
| Can overexpression of B2M enhance antigen presentation? | B2M overexpression cell line |
| What is the role of RNF185 in tapasin degradation? | RNF185 knockout or knockdown |
| How does a viral inhibitor block TAP function? | TAP1/2 knockout with viral protein expression |
| Does endolysosomal MHC I assembly contribute to cross-presentation? | Knock-in of tagged MHC I |
How to Study the peptide antigen assembly with MHC class I protein complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Immunoprecipitation + MS | Peptide repertoire and interacting proteins | Identify immunopeptidome |
| Flow cytometry | Surface MHC class I levels | Assess assembly efficiency |
| CRISPR knockout screen | Genes required for MHC I presentation | Discover novel regulators |
| In vitro peptide binding assay | Peptide-MHC affinity | Study tapasin editing |
| Western blot | Protein expression of PLC components | Validate knockout efficiency |
| Confocal microscopy | Subcellular localization of MHC I | Track ER to surface transport |
| RNA-seq | Transcriptional changes in assembly genes | Analyze interferon response |
Immunoprecipitation and Mass Spectrometry
Immunoprecipitation of MHC class I complexes followed by mass spectrometry allows identification of bound peptides and associated proteins, providing a snapshot of the immunopeptidome.
Flow Cytometry
Flow cytometry using antibodies against MHC class I or tagged peptides measures surface expression levels and can assess the impact of gene knockouts on assembly.
CRISPR Screens
Genome-wide CRISPR knockout screens coupled with MHC class I surface staining can identify novel regulators of peptide assembly.
In Vitro Peptide Loading Assays
Using purified MHC class I molecules and fluorescently labeled peptides, researchers can measure binding affinity and kinetics, and test the effect of tapasin or ERAP1.
How CRISPR Can Be Used to Study GO:0002502 peptide antigen assembly with MHC class I protein complex
Knockout
CRISPR knockout of genes such as B2M, TAP1, TAPBP, or ERAP1 in cell lines (e.g., HeLa, HEK293T) abolishes or severely impairs peptide assembly, providing a clean background to study the pathway. These models are essential for validating the role of specific components in MHC class I surface expression.
Point Mutation
Introducing disease-associated point mutations (e.g., in ERAP1 or HLA-A) via CRISPR base editing or homology-directed repair allows researchers to dissect the functional consequences of specific alleles on peptide trimming and presentation.
Knock-in
Knock-in of tagged MHC class I heavy chains (e.g., GFP or HA tag) enables real-time tracking of assembly and trafficking in live cells, and facilitates affinity purification of peptide-MHC complexes.
Overexpression
Overexpression of tapasin or ERp57 can enhance peptide loading and surface MHC class I levels, useful for boosting antigen presentation in vaccine or immunotherapy research.
How EDITGENE Supports peptide antigen assembly with MHC class I protein complex Research
Researchers studying peptide antigen assembly with MHC class I protein complex-related genes often need to determine whether a candidate gene is causally involved in the pathway or merely correlated. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell models, enabling functional validation of genes in this pathway.
Contact EDITGENE today to design your custom CRISPR model for peptide antigen assembly with MHC class I protein complex research.
Frequently Asked Questions About peptide antigen assembly with MHC class I protein complex
What is GO:0002502?
GO:0002502 is the biological process of binding a peptide to the antigen-binding groove of an MHC class I protein complex, a key step in antigen presentation to CD8+ T cells.
What genes are involved in peptide antigen assembly with MHC class I protein complex?
Key genes include HLA-A, HLA-B, HLA-C, B2M, TAP1, TAP2, TAPBP (tapasin), PDIA3 (ERp57), CALR, and ERAP1/2.
Where does peptide antigen assembly with MHC class I protein complex occur?
It primarily occurs in the endoplasmic reticulum, but can also occur in endolysosomal compartments.
What is the role of tapasin in this process?
Tapasin bridges MHC class I to TAP and acts as a peptide editor, ensuring high-affinity peptides are loaded.
How is peptide antigen assembly with MHC class I protein complex regulated?
It is regulated by the RNF185/Membralin ubiquitin ligase complex, ERAP1/2 trimming, and interferon-induced immunoproteasome subunits.
What diseases are associated with defects in this process?
Defects are linked to cancer immune evasion, viral infections, autoimmune diseases, and bare lymphocyte syndrome type I.
How can CRISPR be used to study this pathway?
CRISPR knockout, knock-in, and point mutation models allow functional dissection of genes like B2M, TAP1, and ERAP1.
What methods are used to study peptide antigen assembly?
Common methods include immunoprecipitation-mass spectrometry, flow cytometry, CRISPR screens, and in vitro peptide binding assays.
What is the immunopeptidome?
The immunopeptidome is the repertoire of peptides presented by MHC molecules on the cell surface, shaped by the assembly pathway.
Can MHC class I assembly occur outside the ER?
Yes, recent evidence shows MHC class I can also assemble with peptides in endolysosomal compartments.
Conclusion
Peptide antigen assembly with MHC class I protein complex (GO:0002502) is a cornerstone of adaptive immunity, enabling the presentation of intracellular antigens to CD8+ T cells. The process involves a sophisticated molecular machinery that ensures high-affinity peptide selection and is tightly regulated. Dysregulation of this pathway contributes to cancer, infections, and autoimmunity, making it a prime target for therapeutic intervention. Advances in CRISPR technology and immunopeptidomics continue to unravel the complexities of this essential biological process.
References
- 1. Blum JS et al.. 2013. Pathways of antigen processing.. Annu Rev Immunol 31:443-73 PMID: 23298205
- 2. van de Weijer ML et al.. 2024. Tapasin assembly surveillance by the RNF185/Membralin ubiquitin ligase complex regulates MHC-I surface expression.. Nat Commun 15(1):8508 PMID: 39353943
- 4. Olson E et al.. 2023. Major histocompatibility complex class I assembly within endolysosomal pathways.. Curr Opin Immunol 84:102356 PMID: 37379719
- 5. Zaitoua AJ et al.. 2020. Variations in MHC class I antigen presentation and immunopeptidome selection pathways.. F1000Res 9 PMID: 33014341
- 6. Thomas C et al.. 2021. MHC I assembly and peptide editing - chaperones, clients, and molecular plasticity in immunity.. Curr Opin Immunol 70:48-56 PMID: 33689959
- 7. Raghavan M et al.. 2008. MHC class I assembly: out and about.. Trends Immunol 29(9):436-43 PMID: 18675588
